Congestive Heart Failure (CHF) Treatment Devices Market Share

Market Share of Congestive Heart Failure (CHF) Treatment Devices Industry

The congestive heart failure (CHF) treatment devices market is moderately consolidated, in terms of competition, with major international companies competing with each other. Companies are more focused on developing high-utility products which can deliver personalized care. Some of the major market players include Jarvik Heart Inc., Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, and Biotronik SE & Co. KG, among others.

Congestive Heart Failure (CHF) Treatment Devices Market Leaders

1. Boston Scientific Corporation

2. Abbott Laboratories

3. Biotronik SE & Co. KG

4. Jarvik Heart Inc.

5. Medtronic PLC

*Disclaimer: Major Players sorted in no particular order